These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
939 related items for PubMed ID: 11571575
1. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells. Lowe SL, Rubinchik S, Honda T, McDonnell TJ, Dong JY, Norris JS. Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575 [Abstract] [Full Text] [Related]
2. Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer. Li X, Marani M, Yu J, Nan B, Roth JA, Kagawa S, Fang B, Denner L, Marcelli M. Cancer Res; 2001 Jan 01; 61(1):186-91. PubMed ID: 11196158 [Abstract] [Full Text] [Related]
3. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells. Kaliberov S, Stackhouse MA, Kaliberova L, Zhou T, Buchsbaum DJ. Gene Ther; 2004 Apr 01; 11(8):658-67. PubMed ID: 14973547 [Abstract] [Full Text] [Related]
4. Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer. Xie X, Zhao X, Liu Y, Zhang J, Matusik RJ, Slawin KM, Spencer DM. Cancer Res; 2001 Sep 15; 61(18):6795-804. PubMed ID: 11559553 [Abstract] [Full Text] [Related]
5. A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression. Rubinchik S, Wang D, Yu H, Fan F, Luo M, Norris JS, Dong JY. Mol Ther; 2001 Nov 15; 4(5):416-26. PubMed ID: 11708878 [Abstract] [Full Text] [Related]
6. A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo. Gu J, Zhang L, Huang X, Lin T, Yin M, Xu K, Ji L, Roth JA, Fang B. Oncogene; 2002 Jul 18; 21(31):4757-64. PubMed ID: 12101414 [Abstract] [Full Text] [Related]
7. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line. Zhang L, Gu J, Lin T, Huang X, Roth JA, Fang B. Gene Ther; 2002 Sep 18; 9(18):1262-70. PubMed ID: 12215894 [Abstract] [Full Text] [Related]
8. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer. Arafat WO, Gómez-Navarro J, Xiang J, Barnes MN, Mahasreshti P, Alvarez RD, Siegal GP, Badib AO, Buchsbaum D, Curiel DT, Stackhouse MA. Mol Ther; 2000 Jun 18; 1(6):545-54. PubMed ID: 10933979 [Abstract] [Full Text] [Related]
9. Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix. Huh WK, Gomez-Navarro J, Arafat WO, Xiang J, Mahasreshti PJ, Alvarez RD, Barnes MN, Curiel DT. Gynecol Oncol; 2001 Nov 18; 83(2):370-7. PubMed ID: 11606099 [Abstract] [Full Text] [Related]
10. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R. Cancer Res; 1995 Oct 01; 55(19):4438-45. PubMed ID: 7671257 [Abstract] [Full Text] [Related]
11. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells. Hasenjäger A, Gillissen B, Müller A, Normand G, Hemmati PG, Schuler M, Dörken B, Daniel PT. Oncogene; 2004 Jun 03; 23(26):4523-35. PubMed ID: 15064710 [Abstract] [Full Text] [Related]
12. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Hemmati PG, Gillissen B, von Haefen C, Wendt J, Stärck L, Güner D, Dörken B, Daniel PT. Oncogene; 2002 May 09; 21(20):3149-61. PubMed ID: 12082630 [Abstract] [Full Text] [Related]
13. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells. Yang HL, Dong YB, Elliott MJ, Liu TJ, McMasters KM. Clin Cancer Res; 2000 Apr 09; 6(4):1579-89. PubMed ID: 10778992 [Abstract] [Full Text] [Related]
14. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ. Breast Cancer Res Treat; 2009 Sep 09; 117(1):45-54. PubMed ID: 18791823 [Abstract] [Full Text] [Related]
15. Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24. Lebedeva IV, Sarkar D, Su ZZ, Kitada S, Dent P, Stein CA, Reed JC, Fisher PB. Oncogene; 2003 Nov 27; 22(54):8758-73. PubMed ID: 14647471 [Abstract] [Full Text] [Related]
16. Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer. Shariat SF, Desai S, Song W, Khan T, Zhao J, Nguyen C, Foster BA, Greenberg N, Spencer DM, Slawin KM. Cancer Res; 2001 Mar 15; 61(6):2562-71. PubMed ID: 11289132 [Abstract] [Full Text] [Related]
17. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis. Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood DP, Sarkar FH. Int J Oncol; 2003 Apr 15; 22(4):787-94. PubMed ID: 12632069 [Abstract] [Full Text] [Related]
18. Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft. Huang X, Lin T, Gu J, Zhang L, Roth JA, Stephens LC, Yu Y, Liu J, Fang B. Gene Ther; 2002 Oct 15; 9(20):1379-86. PubMed ID: 12365003 [Abstract] [Full Text] [Related]
19. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC. Cancer Res; 2003 Nov 15; 63(22):7840-4. PubMed ID: 14633711 [Abstract] [Full Text] [Related]
20. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells. Drew L, Fine RL, Do TN, Douglas GP, Petrylak DP. Clin Cancer Res; 2002 Dec 15; 8(12):3922-32. PubMed ID: 12473608 [Abstract] [Full Text] [Related] Page: [Next] [New Search]